⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Official Title: Phase 2 Multicenter Prospective Open Label 2-Dose Level Clinical Safety and Efficacy Evaluation of Injection of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Study ID: NCT01620515

Conditions

Prostate Cancer

Study Description

Brief Summary: This study is designed to evaluate the safety and efficacy of a single injection of NX-1207 for the treatment of biopsy-confirmed low risk localized (T1c) prostate cancer in patients currently undergoing active surveillance. Study participants currently on active surveillance will be randomized either to treatment with a single intraprostatic injection of NX-1207 (2.5 mg or 15 mg) followed by active surveillance or to no treatment (continued active surveillance). Blinded efficacy evaluation will be by a second post-treatment prostate biopsy.

Detailed Description:

Eligibility

Minimum Age: 45 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

For information concerning this clinical site, please contact Nymox at 800-936-9669., Tucson, Arizona, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Atherton, California, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., La Mesa, California, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Long Beach, California, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., San Diego, California, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Denver, Colorado, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Englewood, Colorado, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., New Britain, Connecticut, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Aventura, Florida, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Naples, Florida, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Jeffersonville, Indiana, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Shreveport, Louisiana, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Annapolis, Maryland, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Baltimore, Maryland, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Las Vegas, Nevada, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Brick, New Jersey, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Albuquerque, New Mexico, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Garden City, New York, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., New York, New York, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Myrtle Beach, South Carolina, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Germantown, Tennessee, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Carrollton, Texas, United States

For information concerning this clinical site, please contact Nymox at 800-936-9669., Salt Lake City, Utah, United States

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: